Brief: Lidds Receives Approval From MPA To Start Phase I Study NZ-DTX-001

Lidds AB

13/11/2018 07:48

Nov 13 (Reuters) - Lidds AB  LIDDS.ST :
    * REG-LIDDS RECEIVES APPROVAL FROM MPA (SWEDISH MEDICAL PRODUCT AGENCY) TO START PHASE I
STUDY
NZ-DTX-001

Source text for Eikon:  ID:nGNE490W1Y 
Further company coverage:  LIDDS.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))